SAN DIEGO, Feb. 14, 2023 /PRNewswire/ -- Eurofins Discovery, the leading provider of products and services to the drug discovery industry, today announced its collaboration with Invasight, a Switzerland-based biotech developing cancer therapies. The collaboration focuses on advancing first-in-class, small molecule, protein-protein interaction antagonists (PPIAs) against a protein that causes cancer cell invasion.
Eurofins Discovery Announces Acquisition of DiscoveryBioMed
Eurofins DiscoverX Products LLC, a leader in assays for drug discovery, development, and QC lot release, has expanded its Bioassay Certification Program through its certification of KBI Biopharma Inc. (KBI), a JSR Life Sciences company.
ST. CHARLES, Mo., May 18, 2021 /PRNewswire/ -- Eurofins Discovery, the market leader in pharmacology services and drug discovery products with over forty years providing solutions for the pharmaceutical and biotech industry, announces the launch of new services in support of clients working to address the immune consequences of SARS-CoV-2 and other infectious disease. Developed by Eurofins Discovery Phenotypic Center of Excellence, these human primary cell systems provide concept to clinic insights derived from evaluation of protein biomarkers specifically chosen for relevance to COVID-19.
Eurofins Discovery, a provider of services and products to the drug discovery industry, has formed a collaboration with Amphilix AG, a Swiss-based biotech company, to support a program aimed at identifying a treatment modulating key disease mechanisms. Amphilix AG will use Eurofins Discovery's DiscoveryOne offering, an integrated drug discovery platform providing support to progress programs to preclinical development and beyond.
Eurofins Discovery is expanding its footprint to serve the growing market of outsourced drug discovery with its chemistry capabilities. Eurofins Villapharma is Eurofins Discovery's flagship center for synthetic chemistry, focused on supporting growth in chemistry services and Eurofins Discovery's integrated drug discovery business, branded DiscoveryOne.
ST. CHARLES, Mo., April 13, 2020 /PRNewswire/ -- Eurofins Discovery's mission is to support Pharmaceutical and Biotech companies in their efforts to accelerate drug discovery research and development. The COVID-19 crisis is putting the focus on the need for drugs and vaccines to treat patients and provide protection to the global population. Through its worldwide presence, depth of scientific experience, and breadth of assays and services, Eurofins Discovery is striving to provide expert support in identifying and assessing potential drug targets.
Cough syrup had nothing to do with children deaths: Digital Vision owner
It’s a tale as old as time: Drug development can be a slow, expensive and laborious task and, more often than not, yields failure.
Eurofins Discovery Announces Collaboration with Escient Pharmaceuticals